Print

Purpose

The purpose of this study is to test the performance of the AID-P across 21 sites in the Parkinson Study Group. Each site will perform imaging, clinical scales, diagnosis, and will upload the data to the web-based software tool. The clinical diagnosis will be blinded to the diagnostic algorithm and the imaging diagnosis will be compared to the movement disorders trained neurologist diagnosis.

Conditions

Eligibility

Eligible Ages
Between 40 Years and 80 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Parkinson's disease diagnosis within 5-9 years of baseline date - MSAp diagnosis - PSP diagnosis

Exclusion Criteria

  • metal implants in the body that preclude an MRI (pacemaker, metallic clip, neurostimulator, etc) - claustrophobia - pregnancy

Study Design

Phase
Study Type
Observational
Observational Model
Case-Control
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Parkinson's disease Clinically diagnosed Parkinson's disease
  • Diagnostic Test: AIDP
    Machine learning algorithm of imaging data
Multiple System Atrophy, Parkinsonian variant Clinically diagnosed Multiple System Atrophy, Parkinsonian variant
  • Diagnostic Test: AIDP
    Machine learning algorithm of imaging data
Progressive Supranuclear Palsy Clinically diagnosed Progressive Supranuclear Palsy
  • Diagnostic Test: AIDP
    Machine learning algorithm of imaging data

Recruiting Locations

University of Alabama at Birmingham
Birmingham, Alabama 35294
Contact:
Candace Cromer, BS
205-996-4034
candacecromer@uabmc.edu

More Details

Status
Recruiting
Sponsor
University of Florida

Study Contact

David Vaillancourt, PhD
352-294-1770
vcourt@ufl.edu

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.